Boston Scientific Corp - Other Cashflows From Financing Activities
Boston Scientific Corp's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Cashflows-From-Financing-Activities" stands at -0.003 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 12/31/2020.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.134 Billion United States Dollars compared to the value the year prior.
The 1 year change is 0.134 Billion United States Dollars.
The 3 year change is 0.503 Billion United States Dollars.
The 5 year change is -0.109 Billion United States Dollars.
The 10 year change is 1.00 Billion United States Dollars.
The Serie's change in United States Dollars from it's minimum value, on 03/31/2019, to it's latest available value, on 09/30/2025, is +1.01 Billion.
The Serie's change in United States Dollars from it's maximum value, on 06/30/2014, to it's latest available value, on 09/30/2025, is -1.95 Billion.
Other Cashflows From Financing Activities for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Abbott Laboratories - Other Cashflows From Financing Activities | 217,696,616,448.00 |
 | Intuitive Surgical Inc - Other Cashflows From Financing Activities | 206,245,888,000.00 |
 | EssilorLuxottica S. A. - Other Cashflows From Financing Activities | 172,241,486,586.05 |
 | Danaher Corporation - Other Cashflows From Financing Activities | 162,006,663,168.00 |
 | Stryker Corporation - Other Cashflows From Financing Activities | 139,209,850,880.00 |